Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis
暂无分享,去创建一个
L. Moldawer | P. Efron | S. Brakenridge | F. Moore | A. Mohr | Lauren S Kelly | Dijoia B. Darden | G. Ghita | Brittany P Fenner | Lauren S. Kelly
[1] B. Brumback,et al. Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) after sepsis. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.
[2] L. Moldawer,et al. Immunological Endotyping of Chronic Critical Illness After Severe Sepsis , 2021, Frontiers in Medicine.
[3] B. Brumback,et al. DISTINCT IMMUNOLOGIC ENDOTYPES ARE ASSOCIATED WITH CLINICAL TRAJECTORY AFTER SEVERE BLUNT TRAUMA AND HEMORRHAGIC SHOCK. , 2020, The journal of trauma and acute care surgery.
[4] G. O’Keefe,et al. Persistent metabolomic alterations characterize chronic critical illness after severe trauma , 2020, The journal of trauma and acute care surgery.
[5] B. Brumback,et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study , 2020, Critical Care.
[6] B. Brumback,et al. Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term Survival , 2020, Journal of the American Geriatrics Society.
[7] S. Anton,et al. Current Epidemiology of Surgical Sepsis: Discordance Between Inpatient Mortality and 1-Year Outcomes. , 2019, Annals of surgery.
[8] Octavia M Peck Palmer,et al. Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis , 2019, JAMA network open.
[9] C. Coopersmith,et al. Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)* , 2019, Critical care medicine.
[10] B. Brumback,et al. The Development of Chronic Critical Illness Determines Physical Function, Quality of Life, and Long-Term Survival Among Early Survivors of Sepsis in Surgical ICUs* , 2019, Critical care medicine.
[11] D. Herndon,et al. Burn Injury May Have Age-Dependent Effects on Strength and Aerobic Exercise Capacity in Males. , 2018, Journal of burn care & research : official publication of the American Burn Association.
[12] H. Ueno,et al. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy , 2018, Front. Immunol..
[13] R. Hotchkiss,et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. , 2018, JCI insight.
[14] A. Mebazaa,et al. Protracted immune disorders at one year after ICU discharge in patients with septic shock , 2018, Critical Care.
[15] Derek C. Angus,et al. Enhancing Recovery From Sepsis: A Review , 2018, JAMA.
[16] B. Brumback,et al. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients , 2017, The journal of trauma and acute care surgery.
[17] B. Brumback,et al. The Epidemiology of Chronic Critical Illness After Severe Traumatic Injury at Two Level–One Trauma Centers* , 2017, Critical care medicine.
[18] Susan Gruber,et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 , 2017, JAMA.
[19] B. Brumback,et al. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.
[20] Y. Vodovotz,et al. The role of NIGMS P50 sponsored team science in our understanding of multiple organ failure. , 2017, The journal of trauma and acute care surgery.
[21] B. Brumback,et al. Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients , 2017, BMJ Open.
[22] B. Brumback,et al. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock , 2017, Annals of surgery.
[23] R. Martindale,et al. Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. , 2017, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[24] L. Moldawer,et al. Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome , 2017, Critical care medicine.
[25] M. D. Hashem,et al. Early Mobilization and Rehabilitation in the ICU: Moving Back to the Future , 2016, Respiratory Care.
[26] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[27] N. Anstey,et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients , 2014, Critical Care.
[28] S. Reis,et al. Risk of cardiovascular events in survivors of severe sepsis. , 2014, American journal of respiratory and critical care medicine.
[29] J. Marshall. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[30] P. Pronovost,et al. Physical Complications in Acute Lung Injury Survivors: A Two-Year Longitudinal Prospective Study , 2014, Critical care medicine.
[31] D. Herndon,et al. Survivors Versus Nonsurvivors Postburn: Differences in Inflammatory and Hypermetabolic Trajectories , 2014, Annals of surgery.
[32] A. Gabrielli,et al. Computer versus paper system for recognition and management of sepsis in surgical intensive care , 2014, The journal of trauma and acute care surgery.
[33] W. Saris,et al. Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. , 2012, The American journal of clinical nutrition.
[34] L. Moldawer,et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.
[35] R. Tompkins,et al. The Glue Grant experience: characterizing the post injury genomic response , 2011, European Journal of Trauma and Emergency Surgery.
[36] B. McKinley,et al. Computer protocol facilitates evidence-based care of sepsis in the surgical intensive care unit. , 2011, The Journal of trauma.
[37] L. Kao,et al. The epidemiology of sepsis in general surgery patients. , 2011, The Journal of trauma.
[38] D. Heyland,et al. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. , 2011, Journal of the American College of Surgeons.
[39] P. Pronovost,et al. Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.
[40] Peter Bauer,et al. Sepsis mortality prediction based on predisposition, infection and response , 2008, Intensive Care Medicine.
[41] M. Braga,et al. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. , 2005, Nutrition.
[42] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[43] C. Moorehead. All rights reserved , 1997 .
[44] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[45] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[46] S. Brakenridge,et al. Chronic Critical Illness: Application of What We Know. , 2018, Nutrition in clinical practice.